Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in First-Episode and Drug-naive Patients With Schizophrenia

NCT00686140 is registered in ClinicalTrials.gov with Beijing HuiLongGuan Hospital as lead sponsor.

NCT NCT00686140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00686140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in First-Episode and Drug-naive Patients With Schizophrenia
Lead sponsor
Beijing HuiLongGuan Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2006
Completion date
March 31, 2008
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia